SCHEMBL4892079

SCHEMBL4892079

CC(C)Oc1ccc([C@H]2CCNC[C@H]2C)cc1Cl

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SLC6A4 P31645 11/20 0.44
SLC6A3 Q01959 9/20 0.44
SLC6A2 P23975 8/20 0.44
CYP2D6 P10635 3/20 0.42
CSNK2A1 P68400 2/20 0.40
S1PR1 P21453 2/20 0.38
RORC P51449 1/20 0.36
HTR2A P28223 2/20 0.36
HTR2B P41595 2/20 0.36
HTR2C P28335 1/20 0.36
HTR1A P08908 1/20 0.36
HTR1D P28221 1/20 0.36
HTR1B P28222 1/20 0.36
HTR1E P28566 1/20 0.36
HTR7 P34969 1/20 0.36
HTR3A P46098 1/20 0.36
HTR5A P47898 1/20 0.36
HTR6 P50406 1/20 0.36
KCNH2 Q12809 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4892063 1.00 SLC6A4 (0.44) SLC6A4SLC6A3SLC6A2CYP2D6CSNK2A1
SCHEMBL4892069 1.00 SLC6A4 (0.44) SLC6A4SLC6A3SLC6A2CYP2D6CSNK2A1
SCHEMBL4885966 0.85 SLC6A2 (0.44) SLC6A4SLC6A3SLC6A2CYP2D6HTR2A
SCHEMBL4892085 0.81 SSTR1 (0.39) SLC6A4SLC6A3SLC6A2CYP2D6HTR2A
SCHEMBL4892077 0.81 SSTR1 (0.39) SLC6A4SLC6A3SLC6A2CYP2D6HTR2A
SCHEMBL4892067 0.81 SSTR1 (0.39) SLC6A4SLC6A3SLC6A2CYP2D6HTR2A
SCHEMBL5584880 0.80 SLC6A4 (0.45) SLC6A4SLC6A3SLC6A2CSNK2A1S1PR1
Hydrochloric Acid SCHEMBL4930544 0.76 SLC6A2 (0.45) SLC6A4SLC6A3SLC6A2CYP2D6HTR2A
Hydrochloric Acid SCHEMBL4930560 0.76 SLC6A2 (0.45) SLC6A4SLC6A3SLC6A2CYP2D6HTR2A
Hydrochloric Acid SCHEMBL4930552 0.76 SLC6A2 (0.45) SLC6A4SLC6A3SLC6A2CYP2D6HTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080312271-A1 AZABENZIMIDAZOLYL COMPOUNDS PFIZER INC. 2008-12-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080312271-A1 AZABENZIMIDAZOLYL COMPOUNDS AZI2, PAICS, UGT2B7 SLC6A4 719/4885SLC6A3 903/4885SLC6A2 1043/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.